1] Institut Pasteur, Parasite Molecular Immunology Unit, 75724 Paris Cedex 15, France [2] Centre National de la Recherche Scientifique, Unité de Recherche Associée 2581, 75724 Paris Cedex 15, France [3] Institut Pasteur, Genetics and Genomics of Insect Vectors Unit, 75724 Paris Cedex 15, France (F.A.); Institut Pasteur, Functional Genetics of Infectious Diseases Unit, 75724 Paris Cedex 15, France (J.B.); Centre de Physiopathologie de Toulouse-Purpan, Institut National de la Santé et de la Recherche Médicale UMR1043, Centre National de la Recherche Scientifique UMR5282, Université Toulouse III, 31024 Toulouse Cedex 3, France Institut Pasteur, Unité de Biologie et Génétique du Paludisme, Team Malaria Targets and Drug Development, 75724 Paris Cedex 15, France (J.-C.B.).
Institut Pasteur du Cambodge, Malaria Molecular Epidemiology Unit, Phnom Penh, Cambodia.
Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.
Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo. Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia. Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance. K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.
疟原虫对青蒿素衍生物的耐药性在东南亚地区威胁到全球的疟疾控制和消除活动。为了监测青蒿素耐药性的传播,迫切需要一种分子标记。在这里,我们使用来自非洲的青蒿素耐药虫株的全基因组测序和来自柬埔寨的临床寄生虫分离株,将 PF3D7_1343700 氯喹螺旋桨结构域(“K13-螺旋桨”)中的突变与体外和体内的青蒿素耐药性相关联。突变的 K13-螺旋桨等位基因在耐药性流行的柬埔寨省份聚集,占主导地位的突变 K13-螺旋桨等位基因的频率增加与柬埔寨西部最近耐药性的传播相关。突变等位基因的存在与体外寄生虫存活率和体内寄生虫清除率之间存在很强的相关性,表明 K13-螺旋桨突变是青蒿素耐药性的重要决定因素。K13-螺旋桨多态性构成了一个有用的分子标记,可用于大规监测努力,以遏制大湄公河次区域的青蒿素耐药性并防止其全球传播。